NEBIVOLOL EVOLUGEN 5 mg, tablet quadrisectable 30 tablets
Active ingredients: (S,R,R,R)-nebivolol hydrochloride, Nebivolol
Commercialized according to BDPMDispensing in France: Prescription only
Tablet quadrisectable30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEBIVOLOL EVOLUGEN 5 mg, comprimé quadrisécable
- Pharmaceutical form
- comprimé quadrisécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Jan 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60437428CIP73983351CIP133400939833514Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE NÉBIVOLOLcomprimé | 5,45 mg · un comprimé | SA |
| NÉBIVOLOL BASEcomprimé | 5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.